Regulation of Coagulation in Orthopedic Surgery to Prevent DVT and PE, a Controlled, Double-blind, Randomized Study of BAY 59-7939 in the Extended Prevention of VTE in Patients Undergoing Elective Total Hip Replacement

NCT00332020 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2457

Enrollment

INDUSTRY

Sponsor class

Conditions

Prevention
Venous Thromboembolism

Interventions

DRUG: Rivaroxaban (BAY59-7939)
DRUG: Enoxaparin

Sponsor

Bayer